Overview
Spencer Talbot is an associate in Robins Kaplan’s Antitrust and Trade Regulation Group, where he represents clients in complex antitrust matters. His experience includes antitrust class actions, competitor disputes, and government investigations in matters involving allegations of price-fixing, monopolization, information exchanges, algorithmic pricing, market allocation, and other anticompetitive conduct.
Spencer has represented plaintiffs, defendants, and third parties in antitrust litigation and before regulators. He also advises clients on assessing and managing antitrust risk. His work spans numerous industries, including pharmaceuticals, life sciences, technology, consumer goods, entertainment, retail, construction, and hospitality.
Having worked on multiple sides of antitrust disputes, Spencer brings a well-rounded perspective to developing litigation strategy and evaluating risk. He draws on his experience representing plaintiffs, defendants, and third parties—as well as his federal judicial clerkship—to anticipate how opposing parties, regulators, and courts may evaluate a client’s position.
Before joining Robins Kaplan, Spencer practiced as an antitrust associate at a large international law firm in New York and clerked for two federal district court judges in the U.S. District Court for the Eastern District of California.
Spencer earned his J.D. from Cornell Law School, where he served as a Notes Editor for the Cornell Law Review. He received his B.A. from the University of California, San Diego.
Credentials
Education
-
Cornell Law School (2022); Cornell Law Review, Notes Editor (2020-2022)
-
University of California, San Diego, B.A. in Comparative Politics and International Business, cum laude, Phi Beta Kappa (2019)
Selected Results
Representative Matters
- Represented Bruker in antitrust claims against 10x Genomics and Harvard College for allegedly monopolizing the worldwide Single-Cell Spatial Transcriptomics market by refusing to license at-issue patents. 10X Genomics, Inc. et al. v. Bruker Spatial Biology Inc. et al., No. 1:22-cv-00261 (D. Del.) (Prior to joining Robins Kaplan LLP)
- Represented Regeneron Pharmaceuticals in connection with monopolization, restraint of trade, and other claims against Novartis Pharmaceuticals and Vetter Pharma relating to actions taken to prevent Regeneron from competing in the anti-VEGF pre-filled syringe market. Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG, et al., 1:20-cv-05502 (S.D.N.Y.) (Prior to joining Robins Kaplan LLP)
- Represented Serta Simmons Bedding in connection with the FTC investigation, and subsequent litigation, of Tempur Sealy’s acquisition of Mattress Firm. Federal Trade Commission v. Tempur Sealy International, Inc. and Mattress Firm Group Inc., No. 4:24-cv-02508 (S.D. Tex.) (Prior to joining Robins Kaplan LLP).
Practices
Admissions
- New York
- U.S. District Court, Southern District of New York
- U.S. District Court, District of Colorado